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The number of patients awaiting heart transplantation hasincreased exponentially during the past 10 years, whilethe number of donor organs has remained unchanged 1.Alternatives to cardiac transplantation, such as left ven-
tricular assist devices (LVADs), have been shown to decrease
mortality and increase the quality of life in patients with end-stage
heart failure 2. It has recently been proposed that these devices may
become a destination therapy for patients with end-stage heart
failure and thus allow definitive treatment for those who otherwise
may not be able to receive or qualify for heart transplantation 3.
Cardiopulmonary bypass (CPB) is routinely required for im-
plantation of LVADs. However, the well-described complications
of CPB may exacerbate multiple organ failure and increase blood
product transfusions during and after the operation. Recent tech-
nologic advances, including cardiac stabilization devices, have
allowed coronary artery bypass surgery to be performed without
CPB. We present a technique for insertion without cardiopulmo-
nary bypass of a HeartMate Vented Electric LVAD (Thoratec
Corporation, Pleasanton, Calif).
Methods
Clinical summary. A 60-year-old man was awaiting heart
transplantation because of severe end-stage heart failure with di-
lated cardiomyopathy. The patient had no history of previous
cardiac operations or percutaneous coronary angioplasties. De-
compensation of his heart failure required transfer to the cardiac
intensive care unit and inotropic support with dobutamine (10
g/[kg · min]), milrinone (0.2 g/[kg · min]), and intra-aortic
balloon pulsation. His cardiac index was 1.6 L/(min · m2).
Transthoracic echocardiography revealed biventricular dilata-
tion with an ejection fraction of 5% and a left ventricular
end-diastolic dimension of 5.9 cm. Mild-to-moderate mitral
regurgitation was evident, and no aortic regurgitation was
noted. Because no donor heart was available, the decision was
made to place the LVAD.
Operative technique. The patient was transported to the oper-
ating room for implantation of a HeartMate Vented Electric
LVAD. After general anesthesia was administered and the patient
was prepared and draped, a median sternotomy was performed,
and the incision was extended to the umbilicus. The pericardium
was opened, revealing a large, dilated heart. The dissection was
continued in the abdomen for placement of the LVAD body in a
preperitoneal position. At this point both pleural cavities were
entered, and pleural fluid was evacuated. The diaphragm was then
detached anteriorly to allow placement of the apical LVAD inflow
cannula in continuation with the preperitoneal space on the left
side of the abdomen. At this point the patient was given 40,000
units of heparin sulfate. The activated clotting time was 1000
seconds.
An aortic cannula was placed in the ascending aortic root, and
a purse-string suture was placed in the right atrium. To stabilize the
heart during LVAD inflow cannula placement, the Medtronic
Starfish (Medtronic, Minneapolis, Minn) retraction system was
deployed. Suction was applied, and the stabilizer pods were placed
on the right ventricular apical area lateral to the left anterior
descending coronary artery. Deep pericardial sutures were placed
4
. With torsion of the heart toward the right and cephalad, mean
arterial and pulmonary pressures were maintained. The HeartMate
apical coring knife (Thoratec Laboratories) was used to slightly
score the left ventricular apical epicardium, creating a marker for
subsequent sewing cuff suture placement. A 2-0 Prolene purse-
string suture (Ethicon, Inc, Somerville, NJ) was placed approxi-
mately 1 cm outside of this original coring circle. To secure the
apical sewing ring, 9 horizontal mattress sutures (2-0 Ethibond;
Ethicon) were placed. These sutures were passed through the
apical sewing ring and then sewn to the myocardium, with suture
passing just outside of the coring circle to just outside of the
purse-string suture. The sutures were pledget supported, and the
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sewing ring was tied down to the myocardium (Figure 1, A). The
sewing ring was placed to encompass the left ventricular tissue core
that would be removed shortly. Next, the LVAD was brought up to
the field, and plastic tie bands were placed around the sewing ring. At
this point a 2-0 Prolene suture was placed through the middle of the
eventual myocardial tissue core for the LVAD inflow and passed
within the coring knife. The coring knife was then placed through the
sewing ring, and the left ventricular apex was cored out (Figure 1, B).
After one ventricular contraction occurred and blood emerged from
the sewing ring, the apical portion of the LVAD body was placed and
secured with plastic tie bands and 2 silk ligatures. The 2-0 purse-string
suture previously placed was snared down to completely tighten the
coring area and sewing cuff (Figure 1, C). At this point the LVAD
was then placed in the preperitoneal space, and the heart was slowly
retracted down and placed back in its original position with removal
of the stabilization device.
The aortic side of the LVAD body remained closed until
outflow cannulation. The aortic conduit was measured, and a
side-biting clamp was placed on the ascending aorta. After aorto-
tomy, the LVAD outflow conduit was sewn to the ascending aorta
with a running 4-0 Prolene suture with an autologous pericardial
pledget. A crossclamp was placed on the outflow conduit near the
aortic anastomosis, and the outflow conduit was connected to the
assist device. The device was deaired through a primary stab
incision in the outflow graft by way of the left ventricular cardiac
output, and the LVAD was actuated with the hand pump. Once
deairing was completed, the outflow conduit clamp was released,
and the LVAD was slowly started. The deairing hole was closed
primarily. LVAD flows of 4 to 5 L/min were reached. Hemostasis
was obtained, and protamine was administered. A pericardial patch
was placed under the LVAD body to buttress the peritoneum, and
the incision was closed in standard fashion. No blood products
were administered during the course of the operation or during the
postoperative period.
Discussion
LVAD insertion can reverse low tissue perfusion and allow reha-
bilitation of the patient with end-stage heart failure who is awaiting
heart transplantation. In addition, LVADs may represent a desti-
nation therapy for patients who are not candidates for heart trans-
plantation.3
Cardiopulmonary bypass can cause multiple disorders, includ-
ing immunologic, hepatic, renal, and respiratory dysfunction.5
Nonetheless, LVAD placement requires access to and insertion of
a cannula into the left ventricular apex. Manipulation of the left
ventricular apex can cause hemodynamic compromise and may not
be well tolerated in patients with end-stage heart failure. Many
patients with end-stage heart failure have multiorgan failure and
would therefore be at risk for complications related to the adverse
sequelae associated with the blood-synthetic interactions of the
CPB circuit. Because off-pump coronary revascularization has
been shown to be efficacious in high-risk patients with similar
comorbidities, we adapted this surgical technique for LVAD im-
plantation.6
To avoid the use of CPB and still allow access to the left
ventricular apex, we chose to stabilize the heart with a cardiac
stabilization device originally designed for off-pump coronary
artery bypass surgery. These devices use suction to fix the heart in
place and allow cephalization of the left ventricular apex without
hemodynamic compromise. The Medtronic Starfish is unique as it
allows fixation through epicardial surfaces other than the left
ventricular apex, including the right ventricular free wall.
It is important to note that our patient did not require blood
products. Elimination of cardiopulmonary bypass reduces platelet
Figure 1. Illustration depicting suture placement for apical sew-
ing cuff for LVAD inflow cannula and cardiac stabilization device
on right ventricular free wall (A). With stabilization of heart,
coring knife is inserted in sewing cuff (B). Once tissue core is
removed, LVAD inflow cannula is placed in left ventricle (C) and
secured.
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destruction and dysfunction, hemodilution, and resulting coagu-
lopathy. Avoidance of blood products may reduce the elevation in
prereactive antibodies commonly observed in patients awaiting
heart transplantation with LVADs.
This communication represents the application of off-pump
technology for inserting a HeartMate Vented Electric LVAD with
a cardiac stabilization device. This technique may reduce the
morbidity and mortality associated with LVAD implantation and
expand the indications for LVADs to patients with end-stage heart
failure. This would be especially beneficial for older high risk
patients not considered heart transplant candidates, such as
those patients enrolled in the REMATCH trial (Randomized
Evaluation of Mechanical Assistance for the Treatment of Con-
gestive Heart Failure).3 Furthermore, for those patients who
require an intracardiac repair (intraventricular thrombus re-
moval or septal defect repairs) necessitating CPB at the time of
the HeartMate Vented Electric LVAD implantation, our tech-
nique would permit off-pump preparation of the sewing cuff
and aortic outflow cannula, thereby reducing CPB support time
and its associated sequelae.
Addendum
The patient described in the preceding brief communication
underwent successful transplantation 278 days (9 months) after
his off-pump HeartMate VE implantation. He is currently recov-
ering at home undergoing rehabilitation.
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Management of aortic insufficiency in patients with left ventricular
assist devices: A simple coaptation stitch method (Park’s stitch)
Soon J. Park, MD,a Kenneth K. Liao, MD,a Romualdo Segurola, MD,a K. P. Madhu, MD,b and Leslie W. Miller, MD,b
Minneapolis, Minn
Left ventricular assist device (LVAD) implantation in-creases survival and quality of life for patients withadvanced heart failure.1 Because of device design, com-petence of the native aortic valve is critically important.
Even trivial aortic insufficiency could worsen with time,2 and the
regurgitant flow could make the device ineffective for hemody-
namic support.
Managing native aortic valve insufficiency at the time of
LVAD implantation has been challenging. Various procedures
to prevent aortic insufficiency have been anecdotally reported
(eg, aortic valve replacement with a bioprosthetic valve or with
a polytetrafluoroethylene patch, or primary closure of the aortic
valve opening).3-5 Such procedures have been performed suc-
cessfully, but they could make surgery more complicated. We
describe a simple coaptation stitch method of dealing with
central aortic insufficiency at the time of LVAD implantation in
2 patients.
Case Summaries
PATIENT 1. A 61-year-old man with a long-standing history of
ischemic cardiomyopathy had a myocardial infarction and was in
cardiogenic shock. The LVAD (HeartMate-XVE, Thoratec Cor-
poration, Pleasanton, Calif) was implanted uneventfully. Because
of patent venous grafts, anastomosis of the outflow graft to the
aorta was completed under aortic crossclamping. Through the
aortotomy incision between two proximal vein grafts we were able
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